M10.269
Drug-induced gout, unspecified knee
Clinical Classification Guidelines
Medical Intelligence & Overview
Drug-induced gout is a form of gout caused primarily by certain medications that lead to elevated levels of uric acid in the blood. When this increase occurs, uric acid crystals can deposit in joints, causing inflammation and pain. Specifically, when this condition affects the knee without a more specific diagnosis, it is classified under the ICD-10 code M10.269. Recognizing this condition is vital for managing symptoms and preventing joint damage.
Causes & Symptoms
Clinical Causes: Use of medications that impair uric acid excretion, such as diuretics (e.g., thiazides, loop diuretics) Medications that increase uric acid production, like low-dose aspirin Chemotherapy drugs that cause rapid cell turnover, leading to increased uric acid levels Certain immunosuppressive drugs used in transplant patients Other drugs that interfere with uric acid metabolism or renal function
Key Symptoms: Sudden onset of joint pain, often severe Swelling and redness in the affected knee Warmth and tenderness around the joint Limited range of motion due to pain and swelling Possible fever during acute episodes
Diagnostic & Treatment
Diagnosis Path: Diagnosis mainly relies on clinical assessment and laboratory tests. Elevated serum uric acid levels can support the diagnosis, but joint aspiration with crystal analysis remains definitive, identifying monosodium urate crystals. Imaging studies, such as ultrasound or X-ray, might show joint inflammation or tophi in chronic cases, but are not primary diagnostic tools for acute gout.
Treatment Protocols: Managing drug-induced gout involves multiple strategies: - Discontinuing or adjusting the medication that is contributing to increased uric acid levels under medical supervision - Using anti-inflammatory medications to reduce joint pain and inflammation, such as NSAIDs or corticosteroids - Lifestyle modifications, including dietary changes to reduce purine intake and increasing hydration - Long-term urate-lowering therapy might be considered to prevent future attacks, especially if hyperuricemia persists - Regular monitoring of uric acid levels and kidney function
Clinical Advice & FAQs
Billing Guidance
Is M10.269 a billable ICD-10 code?
Yes, M10.269 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M10.269?
Clinical documentation must specify the nature of Drug-induced gout, unspecified knee and any associated comorbidities for accurate reporting.
Cite this Clinical Reference